Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare

NCT07145229 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

380

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Gouty Arthritis
Gout Flare
Gout Flares
Acute Gout Flare

Interventions

DRUG: ABP-745 Dose A
DRUG: ABP-745 Dose B
DRUG: Colchicine
DRUG: Placebo

Sponsor

Atom Therapeutics Co., Ltd